Mivebresib (Standard)

• Description:

  Mivebresib (Standard) is the analytical standard of Mivebresib. This product is intended for research and analytical applications. Mivebresib (ABBV-075) is a potent and orally active bromodomain and extraterminal domain (BET) bromodomain inhibitor. Mivebresib binds to BRD4 with a Ki of 1.5 nM[1].

• Product Name Alternative:

  ABBV-075 (Standard)

• UNSPSC:

  12352005

• Target:

  Apoptosis; Epigenetic Reader Domain; Reference Standards

• Related Pathways:

  Apoptosis; Epigenetics; Others

• Field of Research:

  Cancer

• Smiles:

  CCS(=O)(NC1=CC=C(OC2=CC=C(F)C=C2F)C(C3=CN(C)C(C4=C3C=CN4)=O)=C1)=O

• Molecular Formula:

  C22H19F2N3O4S

• Molecular Weight:

  459.47

• References & Citations:

  [1]EJ Faivre et al. Abstract 4694: ABBV-075, a novel BET family inhibitor, disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference Standards

• CAS Number:

  [1445993-26-9]